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whether neutralizing IL-6 or IL-8 before reperfuslOn could
result in improved myocardial preservatIOn.
Many factors have been causally hnked to myocardial
ischemia-reperfusion injury after CPB (Fig I). In fact. three
considerations suggest that IL-6 is unlikely to be a potent
mediator inducmg myocardial injury: (I) IL-6 has been
shown to be a marker rather than a critical mediator of
injury'; (2) IL-6 may have anti-inflammatory etlects through
direct suppression as well as the induction of the natural
antagonist of tumor necrosis factor-a.,.) which is also in-
volved in inducing myocardial dysfunction3; (3) even though
similar IL-6 production was noted in patients undergoing
coronary artery bypass grafting (CABG) through median
sternotomy with or without the use of CPB,5.6 a significantly
lower release of cardiac troponin-I was observed in the off-
pump group.6 These findings indicate IL-6 production
may be mfluenced by the degree of surgical trauma (ie,
surgical incision), without further inducing myocardial
injury.
Sawa and colleagues! reported that FUT-175. a serine
protease inhibitor, could suppress IL-6 production. It is pos-
sible, however, that FUT-175 does not inhibit the release of
IL-6, but merely delays this process. Only two samples were
taken in their study, before ischemia and 10 minutes after
reperfusion. I The peak release of IL-6, however, occurs at
least 2 hours later, simply because it is not a '"washout'"
phenomenon. 7
For its part, IL-8 is a crucial chemokine known to attract
and activate neutrophils as well as T lymphocytes and to con-
trol their trafficking. Clinical investigations have documented
that the myocardium is a major source of IL-8 during reper-
fusion after longer durations of ischemia or after acute
myocardial infarction.3Inasmuch as neutrophil activation is a
critical early step in ischemia-reperfusion injury. it is certainly
not surprising to learn that administration of anti-IL-8 anti-
bodies prevents cardiopulmonary injury.2.8 Indeed, we" have
recently observed a strong correlation between IL-8 produc-
tion and postoperative cardiac troponin-I levels in patients
undergoing CABG. Although we agree with Boyle and col-
leagues" about the important role of IL-8. we believe that
there is no substantial evidence so far for any relevant medi-
ator to be the '"lethal activator."
Before trying to modulate an essentially biologiC functIOn
(ie, inflammation) with multiple antibodies (eg, anti-IL-6,
anti-IL-8, anti-intercellular adhesion molecule-I, anti-
CD 18) as proposed by Sawa and colieagues,l we should also
recognize that the balance among many interactive mediators.
together with their natural antagonists/antibodies or endoge-
nous soluble receptors, may be much more crucial. For
instance, the release of a key anti-inflammatory cytokine IL-
10, which is known to inhibit the productIOn of promflamma-
tory cytokines, is almost proportional to the release of IL-8
during clinical CPB,3 as well as in patients undergoing off-
pump CABG.6
We are just starting to understand the complexities of the
network. We should always make sure to aim our gun at the
right target before opening fire. The continued explosion in
molecular biologic knowledge will help to develop an ideal
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magic bullet or combinations of bullets to modulate rather
than to block an excessive inflammatory response.
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The "sternum calvary"
To the Editor:
We read with great interest the article by Tam, Garlick, and
Almeida! in the October 1997 issue of the Journal and the
related correspondence by Morishita, Kuwaky, Sato, and
Abe.2 The discussion concerns an elegant approach to many
valve operations through a less invasive sternotomy.
We have ditlerent comments related to this approach.
Although minimally invasive direct coronary artery bypass
(MIDCAB) procedures. avoiding cardiopulmonary bypass
(CPB) and cardiopleglc arrest, are truly minimally invasive,
in the field of valve surgery, debates continue over what con-
stitutes "Ie,s invasive" and which incision provides the best
exposure and sufficient space to mampulate the heart. Over
the past 2 years less mvasive approaches to valve surgery
have shown a tendency to switch from paramedian thoraco-
tomy to partial sternotomy. Table I lists different approaches
of partial sternotomy reported in the recent literature.
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Table I
Type ofsternotomy
Superior partial sternotomy
Hockey stick sternotomy
"1" or 'J" sternotomy
Mml-T-sternotomy
Open door method
Lower half mmistemotomy
Mmlsternotomy
LimIted lower sternotomy
Reven,ed Z ,ternotomy
Inverted V-shaped sternotomy
PartIal sternotomy
Mim,ternotomy
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SometImes minimizing access implies maximizing technical
difficulty, and the tremendous imagination of the '"new ster-
notomies" inspired, in our minds, the term '"sternum calvary."
Several surgeons changed from great enthusiasm, to a state
of caution, and finally to evident disappointment regarding
these techniques. By contrast. others have attempted to keep
the flame burning while changing from one method to another,
often turning around almost 360 degrees.
The standard median sternotomy, with its 20-cm skin inci-
SIon, has been the preferred approach since the beginning of
the cardiac surgery era for most types of cardiac operations,
both primary and redo. Although it provided excellent expo-
sure, it proved to be unnecessarily invasive. The large window
over the mediastinum justified sternal and rib fractures and
the extension to the linea alba. Postoperative chest wall func-
tion and total lung compliance were greatly affected and pain
increased. The extensive dissection of the mediastinal tissues
and the deliberate use of cautery and multiple chest tube sites
have been found to be sources of excessive bleeding, wound
infection, and other complications. Last but not least impor-
tant is an unaesthetic scar.
In our minds the '"minimally invasive" philosophy should
influence our profession to simplify the technique for the sur-
geon and to proVIde beneficial results with the least possible
morbidity to the patients. In this sense, the various mimmal-
istic approaches are not really new and certainly do not rep-
resent the "genie out of the bottle" phenomenon that we have
recently read about.
The work of Tam, Garlick, and Almeida introduces into the
debate a most appropriate ''surgical compromise," which is
expressed in the question: "Can we be less inl'Gsive thlVugh
a median sternotomy?"
Our experience of '"less invasive" valve surgery began at the
end of 1996, and to date more than 170 patients have been
operated on with a simple modified median sternotomy that
became the routine approach for all the primary interventions.
The surgical technique and the results in the first 100 patients
have been previously reported.3 The concept of our technique,
named "short cut median sternotomy," includes a median
approach to the heart with a 6- to 9-cm skin incision followed
by a sub-complete, bone-limited median sternotomy without
horizontal transection. The V-shaped sternotomy ends at the
xiphoid process, which remains intact. After the sternal edges
have been opened, limited to 5 to 6 cm, the pericardium is
opened and exposed in the region where the operation is to be
performed. Central CPS and valve surgery are performed with-
out any modifications to the operative techniques. The incision
may be ea,ily and rapidly extended to a standard sternotomy
should techmcal problems be encountered or exposure be inad-
equate. We believe that the median approach has many poten-
tial and practical advantages: The small skin incision with a
limited exposure of the mediastinum reduces the pain from
overstretching of the ribs and thoracic ligaments; postoperative
respiratory function is consequently preserved, especially in
elderly patients. This smaller median sternotomy appears to
heal fast. is stable, and is less painful. There is also less poten-
tial for wound infection and blood loss. Patient recovery is
accelerated, allowing for a shorter hospital stay, with an over-
all reduction in cost. Reoperations should be less difficult.
Finally, the debate over minimally invasive cardiac surgery
will continue, and we would like to take part in answering the
above-mentioned question: "We can be less invasive through a
median sternotomy," being respectful of our surgical heritage
and not using innovative techniques for the wrong reasons.
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